Alpha 2.0
Login Register
» Authors » Lian-Yu Chen

Lian-Yu Chen

Explore the profile of Lian-Yu Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 76
Citations 773
Followers 0
Related Specialties
Psychiatry
General Medicine
Public Health
Top 10 Co-Authors
Zhen Chen
Ramin Mojtabai
Ming-Chyi Huang
Hao Chen
Shu-Yu Yang
Eric C Strain
Chien-Shan Cheng
Hu-Ming Chang
Rosa M Crum
Shih-Ku Lin
Published In
J Formos Med Assoc
Psychiatry Clin Neurosci
PLoS One
Soc Psychiatry Psychiatr Epidemiol
Int J Drug Policy
Affiliations
Soon will be listed here.
Recent Articles
1.
Trends in the use and nonmedical use of sedatives-hypnotics in the population aged 12 to 64 years in Taiwan: a comparative analysis of the national surveys in 2014 and 2018
Tsay W, Chen L, Wu S, Hsiao P, Ting T, Yen C, et al.
BMC Public Health . 2024 Nov; 24(1):3262. PMID: 39581999
Background: Many countries, including Taiwan, have tightened regulations on prescribing sedatives-hypnotics over the concern of their associated adverse health effects. However, it remains seldom investigated whether different age-sex strata have...
2.
Opioid agonist treatment programs and hepatitis C virus elimination in Taiwan: Ways of expanding the care cascade in screening and treatment
Chung Y, Tseng C, Wang S, Huang C, Chen L, Pwu R, et al.
Int J Drug Policy . 2024 Nov; 134:104658. PMID: 39541763
Background: One key population related to achieving the global goal of hepatitis C virus (HCV) elimination is people who inject drugs (PWID). By surveying opioid agonist treatment (OAT) programs nationwide...
3.
Comparative Analysis of School Mental Health Investment Strategies: Insights From Taiwan's Youth Mental Health Support Program
Wei L, Chen L
Psychiatr Serv . 2024 Jul; 75(7):719. PMID: 38946261
No abstract available.
4.
Rapid Screening of New Psychoactive Substances Using pDART-QqQ-MS
Hsu W, Cheng K, Feng T, Chen J, Chen G, Chen L, et al.
J Am Soc Mass Spectrom . 2024 Apr; 35(6):1370-1376. PMID: 38652738
Drug abuse is a severe social problem worldwide. Particularly, the issue of new psychoactive substances (NPSs) have increasingly emerged. NPSs are structural or functional analogs of traditional illicit drugs, such...
5.
Correction: Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis
Chung Y, Tung Y, Wang S, Huang C, Chen L, Chen W
Implement Sci . 2024 Mar; 19(1):28. PMID: 38504271
No abstract available.
6.
Assessing the impact of public funding in alleviating participant reduction and improving the retention rate in methadone maintenance treatment clinics in Taiwan: an interrupted time series analysis
Chung Y, Tung Y, Wang S, Huang C, Chen L, Chen W
Implement Sci . 2024 Feb; 19(1):18. PMID: 38389082
Background: Given the steady decline in patient numbers at methadone maintenance treatment (MMT) clinics in Taiwan since 2013, the government initiated Patients' Medical Expenditure Supplements (PMES) in January 2019 and...
7.
The Use of Premixed Drugs in Commodity Packets in the Population: Prevalence and Correlates Revealed by the 2018 National Survey of Substance Use in Taiwan
Wu S, Chen L, Hsiao P, Ting T, Yen C, Chang S, et al.
J Epidemiol . 2023 Jul; 34(5):218-227. PMID: 37460297
Background: Administering premixed drugs in commodity packets was first reported in Asia in 2015, but there continues to be a dearth of related population-based data. This study aimed at examining...
8.
Risk factors for relapse among methamphetamine users receiving a joint legal-medical treatment program as a diversion intervention: A one-year follow-up study
Huang M, Fang S, Lin C, Lin T, Chang H, Yang T, et al.
J Subst Use Addict Treat . 2023 Feb; 151:208955. PMID: 36804075
Background: Methamphetamine (METH) is a Schedule II illicit drug in Taiwan. A 12-month legal-medical joint intervention program has been developed for first-time METH offenders during deferred prosecution. Risk factors associated...
9.
The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study
Kubota C, Inada T, Lin S, Avasthi A, Chee K, Tanra A, et al.
Hum Psychopharmacol . 2022 Dec; 38(2):e2861. PMID: 36462184
Introduction: Drug-induced extrapyramidal syndrome (EPS) remains a major problem in clinical psychiatry. This study aimed to examine the factor structure of drug-induced extrapyramidal symptoms observed in patients with schizophrenia and...
10.
Toward Evaluating Critical Factors of Extubation Outcome with XCSR-Generated Rules
Huang P, Chen L, Chung W, Sheu C, Hsiao T, Tsai J
Bioengineering (Basel) . 2022 Nov; 9(11). PMID: 36421102
Predicting the correct timing for extubation is pivotal for critically ill patients with mechanical ventilation support. Evidence suggests that extubation failure occurs in approximately 15-20% of patients, despite their passing...